Search research articles
Contact Us
Filters
Showing results (1-10 of 151) with videos related to
Page
of 16
Sort By:
Journal of Clinical Medicine
|
August 23, 2020
Recent Advances in Mycobacterial Research
Vishwanath Venketaraman
Frontiers in Cellular and Infection Microbiology
|
February 27, 2025
Editorial: Non-tuberculous mycobacteria infections and COVID-19
Vishwanath Venketaraman
Frontiers in Immunology
|
November 12, 2015
Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis - A Close View of the Immune System
Vishwanath Venketaraman
Infectious Disease Reports
|
December 23, 2021
SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
Patrida Rangchaikul, Vishwanath Venketaraman
Frontiers in Immunology
|
June 27, 2024
Editorial: Advances in the management of tuberculosis meningitis
Selvakumar Subbian, Vishwanath Venketaraman
Viruses
|
April 26, 2025
Neuroinflammation, Blood-Brain Barrier, and HIV Reservoirs in the CNS: An In-Depth Exploration of Latency Mechanisms and Emerging Therapeutic Strategies
Noor Said, Vishwanath Venketaraman
Recent Patents on Anti-Infective Drug Discovery
|
October 17, 2009
Control of mycobacterium tuberculosis infection by glutathione
Nancy D Connell, Vishwanath Venketaraman
International Journal of Molecular Sciences
|
February 26, 2025
Advances in Host-Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention
Mohammad J Nasiri, Vishwanath Venketaraman
Frontiers in Immunology
|
August 8, 2022
Editorial: Immunometabolic mechanisms underlying the severity of COVID-19
Julia Kzhyshkowska, Vishwanath Venketaraman, Galileo Escobedo
Biomedicines
|
February 26, 2025
Therapeutic Applications of Programmed Death Ligand 1 Inhibitors in Small Cell Lung Cancer
Leena Nabipur, Michael Mouawad, Vishwanath Venketaraman
Page
of 16
Search research articles
Search
Showing results (1-10 of 151) with videos related to
Sort By:
Page
of 16
Journal of Clinical Medicine
|
August 23, 2020
Recent Advances in Mycobacterial Research
Vishwanath Venketaraman
Frontiers in Cellular and Infection Microbiology
|
February 27, 2025
Editorial: Non-tuberculous mycobacteria infections and COVID-19
Vishwanath Venketaraman
Frontiers in Immunology
|
November 12, 2015
Editorial: Causes for Increased Susceptibility to Mycobacterium tuberculosis - A Close View of the Immune System
Vishwanath Venketaraman
Infectious Disease Reports
|
December 23, 2021
SARS-CoV-2 and the Immune Response in Pregnancy with Delta Variant Considerations
Patrida Rangchaikul, Vishwanath Venketaraman
Frontiers in Immunology
|
June 27, 2024
Editorial: Advances in the management of tuberculosis meningitis
Selvakumar Subbian, Vishwanath Venketaraman
Viruses
|
April 26, 2025
Neuroinflammation, Blood-Brain Barrier, and HIV Reservoirs in the CNS: An In-Depth Exploration of Latency Mechanisms and Emerging Therapeutic Strategies
Noor Said, Vishwanath Venketaraman
Recent Patents on Anti-Infective Drug Discovery
|
October 17, 2009
Control of mycobacterium tuberculosis infection by glutathione
Nancy D Connell, Vishwanath Venketaraman
International Journal of Molecular Sciences
|
February 26, 2025
Advances in Host-Pathogen Interactions in Tuberculosis: Emerging Strategies for Therapeutic Intervention
Mohammad J Nasiri, Vishwanath Venketaraman
Frontiers in Immunology
|
August 8, 2022
Editorial: Immunometabolic mechanisms underlying the severity of COVID-19
Julia Kzhyshkowska, Vishwanath Venketaraman, Galileo Escobedo
Biomedicines
|
February 26, 2025
Therapeutic Applications of Programmed Death Ligand 1 Inhibitors in Small Cell Lung Cancer
Leena Nabipur, Michael Mouawad, Vishwanath Venketaraman
Page
of 16